Resolution of left and right ventricular thrombosis secondary to hypereosinophilic syndrome (lymphoproliferative variant) with reduced intensity conditioning allogenic stem cell transplantation

Ann Hematol. 2008 Nov;87(11):937-8. doi: 10.1007/s00277-008-0505-9. Epub 2008 Jun 3.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Female
  • Fibrinolytic Agents / therapeutic use*
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Hypereosinophilic Syndrome / complications*
  • Hypereosinophilic Syndrome / therapy
  • Lymphoma, T-Cell, Peripheral / complications*
  • Lymphoma, T-Cell, Peripheral / therapy
  • Polydeoxyribonucleotides / therapeutic use*
  • Thrombosis / drug therapy*
  • Thrombosis / etiology
  • Transplantation Conditioning*
  • Transplantation, Homologous
  • Ventricular Dysfunction, Left / etiology
  • Ventricular Dysfunction, Right / etiology

Substances

  • Fibrinolytic Agents
  • Polydeoxyribonucleotides
  • defibrotide